Skip to content

Effect of Oral Vitamin D3 on Chronic Rhinosinusitis Treatment in Adults With Lower Vitamin D Levels

Influence of Oral Vitamin D3 on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyposis and Lower Vitamin D Levels

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02668861
Enrollment
40
Registered
2016-01-29
Start date
2016-05-31
Completion date
2017-05-31
Last updated
2016-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Brief summary

The purpose of the study is to test the clinical efficacy of oral Vitamin D3 on Wound Healing in patients with Chronic Rhinosinusitis With Nasal Polyposis and Lower Vitamin D Levels After Endonasal Endoscopic Sinus Surgery

Interventions

DRUGVitamin D

Vitamin D 4000IU/day for 8 weeks

Budesonide Nasal Spray 128ug/d for 8 week

OTHERplacebo

placebo for 8 weeks

Sponsors

The First Affiliated Hospital of Shanxi Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Clinical diagnosis of Chronic Rhinosinusitis with nasal polyps 2. Be 18-60 years old of Chinese people and of either sex,the Han nationality 3. Vitamin D level of less than 30 ng/ml

Exclusion criteria

* 1\. Women must not be pregnant, breast feeding 2. Chronic oral corticosteroid therapy 3. History of physician-diagnosed nephrolithiasis 4. Chronic diseases( diabetes,Hypertension,renal insufficiency, severe liver disease) 5.prior surgeries of the paranasal sinuses 6. With an upper respiratory tract infection within 4 weeks of entering the study

Design outcomes

Primary

MeasureTime frameDescription
VAS evaluation of usual symptoms in patients with CRSwNPat 8 weeks after first drug intakeThe evaluated symptoms were nasal obstruction, anterior nasal discharge and post-nasal drip, smelling reduction and facial pain
Questionnaire:SNOT-20 evaluates the quality of Lifeat 8 weeks after first drug intake
Change of Lund-Kennedy scoresat 8 weeks after first drug intake

Secondary

MeasureTime frame
Inflammatory mediators in serum8 weeks
Histologic analysis of nasal mucosa8 weeks

Countries

China

Contacts

Primary ContactJun Tian
zguotian@126.com13603514451
Backup ContactYing Y Fang
m15703410761@163.com15703410761

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026